AbCellera Biologics Inc. (ABCL) Investor Relations Documents

AbCellera Biologics Inc. (ABCL) investor relations documents from the company's IR site: 10 presentations, 25 press releases; latest deck 2026-08-10. Read in-app with summaries. First-party data.

Presentation: ABCL635 Phase 2 data shows an 83% reduction in moderate-to-severe VMS frequency at week 4, positioning it as a potential best-in-class non-hormonal treatment.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-12Press releaseAbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants
2026-08-11Press releaseAbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
2026-08-10PresentationPresentation
2026-08-10Press releaseAbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in
2026-08-07Press releaseAbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due
2026-08-05Press releasePress Release
2026-08-05Quarterly reportQ2 2026 Earnings Results and Business Update
2026-07-29Press releaseAbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Othe
2026-07-07Press releaseAbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-07Press releaseAbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-06Press releaseDownload , AbCellera Appoints Dr. Lynn Seely to its Board of Directors, July 6, 2026, (opens in new window)
2026-06-17Press releaseDownload , Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multisp
2026-06-05Press releaseDownload , AbCellera Appoints Dr. Victor Sandor to its Board of Directors, June 5, 2026, (opens in new window)
2026-05-11Quarterly reportQ1 2026 Earnings Results and Business Update
2026-05-11Press releaseDownload , AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635, Ma
2026-05-07Press releaseDownload , AbCellera to Present at Upcoming Investor Conferences in May and June 2026, May 7, 2026, (opens in new window
2026-04-20Press releaseDownload , AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call, Ap
2026-04-01Press releaseAbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
2026-04-01Press releaseAbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
2026-02-24Press releaseDownload , AbCellera Reports Full Year 2025 Business Results, February 24, 2026, (opens in new window)
2026-02-11Press releaseDownload , AbCellera to Present at Upcoming Investor Conferences in March and April 2026, February 11, 2026, (opens in n
2026-01-22Press releaseDownload , AbCellera to Report Full Year 2025 Financial Results on February 24, 2026, January 22, 2026, (opens in new wi
2026-01-12Press releaseAbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment
Earnings deckPresentation of Third Quarter 2025, PDF file, (opens in new window)
2025-08-07Quarterly reportQ2 2025 Earnings Results and Business Update
2025-05-08DocumentSEC Filing
2025-05-08Quarterly reportQ1 2025 Earnings Results and Business Update
2025-05-08Earnings deckCall Summary
2025-02-27Earnings deckPresentation of Fourth Quarter 2024, PDF file, (opens in new window)
2025-02-27Press releasePress Release of Fourth Quarter 2024, , (opens in new window)
2025-01-15Presentation43rd Annual JP Morgan Healthcare Conference
2024-11-19PresentationJefferies London Healthcare Conference
2024-11-04Earnings deckCall Summary
2024-11-04Earnings deckPresentation of Third Quarter 2024, PDF file, (opens in new window)
2024-11-04Press releasePress Release of Third Quarter 2024, PDF file, (opens in new window)
2024-08-06Earnings deckCall Summary
2024-08-06Press releasePress Release of Second Quarter 2024, PDF file, (opens in new window)
2024-05-07Press releasePress Release of First Quarter 2024, PDF file, (opens in new window)
2024-05-07Earnings deckPresentation of First Quarter 2024, PDF file, (opens in new window)
2024-02-20Press releasePress Release of Fourth Quarter 2023, PDF file, (opens in new window)

ABCL overview · ABCL earnings · ABCL financials · ABCL KPIs · ABCL documents · ABCL ownership · ABCL peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.